<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T06:42:04Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/11888" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/11888</identifier><datestamp>2026-09-24T03:02:45Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Berti, Paul</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Popović, Vladimir</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Chemical Biology</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-06-18T16:57:23Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-06-18T16:57:23Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="created" lang="en_US">2012-02-02</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2012-04</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">opendissertations/6820</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">7841</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">2490676</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/11888</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/13571</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;p>Sialic acid synthase (NeuB) is a key enzyme in bacterial biosynthesis of the sialic acid &lt;em>N&lt;/em>-acetylneuraminic acid (NeuNAc). It catalyzes the addition of phosphoenolpyruvate (PEP) to &lt;em>N&lt;/em>-acetylmannosamine (ManNAc) in the presence of a divalent cation such as Mn&lt;sup>2+&lt;/sup>. We have explored the inhibition of NeuB by an oxacarbenium ion mimic, NeuNAc oxime, and hydroxylamine (NH&lt;sub>2&lt;/sub>OH). NeuNAc oxime shows slow-binding inhibition with a binding half-life of 2.5 h and an inhibition constant (&lt;em>K&lt;/em>&lt;sub>i&lt;/sub>&lt;sup>*&lt;/sup>) of 1.6(± 0.7) pM. Even though NeuNAc oxime binds NeuB with high affinity, there remains approximately 10% residual activity even after extended pre-incubation with high inhibitor concentrations. In contrast, in the presence of substrates, when NeuB was actively catalyzing NeuNAc synthesis, complete inhibition by NeuNAc oxime was observed within 6 h. This inhibition profile is similar to NH&lt;sub>2&lt;/sub>OH; which has previously been shown to elicit complete, time-dependent inhibition. We propose the existence of two NeuB conformations: an asymmetric idle state conformation (NeuB&lt;sup>IS&lt;/sup>), in which NeuNAc oxime is able to bind to only one monomer of this dimeric enzyme, and a second conformation, running state NeuB (NeuB&lt;sup>RS&lt;/sup>), which is completely inhibited due to either NeuNAc oxime binding to the second monomer, or the dimer adopting a conformation in which the unbound monomer is inactive. Experiments with [1-&lt;sup>14&lt;/sup>C]PEP showed that in the presence of large excess of substrate, inhibition occurred faster than with a lower excess. This suggests that a sustained buildup of NeuB&lt;sup>RS&lt;strong> &lt;/strong>&lt;/sup>is required for complete inhibition.&lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">sialic acid</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">NeuB</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">oxime</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">oxacarbenium ion</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">enzyme inhibition</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">slow-binding inhibitor</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Neiserria meningitidis</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">residual activity</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">NeuNAc</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">siaC</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Neu5Ac</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">NANA</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biochemistry</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Medicinal Chemistry and Pharmaceutics</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Pharmacology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biochemistry</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Inhibition of the bacterial sialic acid synthase, NeuB</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>